- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/08 - Bridged systems
Patent holdings for IPC class C07D 487/08
Total number of patents in this class: 1927
10-year publication summary
|
103
|
110
|
114
|
122
|
136
|
132
|
185
|
190
|
183
|
117
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4898 |
95 |
| Merck Sharp & Dohme LLC | 3748 |
37 |
| Boehringer Ingelheim International GmbH | 4650 |
36 |
| Janssen Pharmaceutica N.V. | 3392 |
34 |
| Gilead Sciences, Inc. | 2036 |
32 |
| Novartis AG | 10849 |
25 |
| F. Hoffmann-La Roche AG | 7925 |
25 |
| Genentech, Inc. | 3976 |
25 |
| Pfizer Inc. | 3387 |
23 |
| Vertex Pharmaceuticals Incorporated | 1597 |
23 |
| Astellas Pharma Inc. | 1088 |
23 |
| Hoffmann-La Roche Inc. | 3418 |
21 |
| Rigel Pharmaceuticals, Inc. | 539 |
18 |
| Incyte Corporation | 1024 |
16 |
| Sanofi | 4055 |
15 |
| Biosplice Therapeutics, Inc. | 171 |
15 |
| Amgen Inc. | 4074 |
13 |
| Astex Therapeutics Limited | 237 |
13 |
| Clarity Pharmaceuticals Limited | 46 |
13 |
| Arvinas Operations, Inc. | 229 |
12 |
| Other owners | 1413 |